We are live on
!
Find out more
SRIM
Saratoga Research & Investment Management Portfolio holdings
AUM
$1.83B
1-Year Est. Return
18.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1B
AUM Growth
+$23.3M
(+2.4%)
Cap. Flow
-$786K
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
46.78%
Holding
57
New
3
Increased
22
Reduced
17
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$3.68M |
| 2 |
Accenture
ACN
|
+$3.4M |
| 3 |
C.H. Robinson
CHRW
|
+$2.99M |
| 4 |
Baxter International
BAX
|
+$2.65M |
| 5 |
Expeditors International
EXPD
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$16.4M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$2.58M |
| 3 |
3M
MMM
|
+$2.33M |
| 4 |
Johnson & Johnson
JNJ
|
+$1.69M |
| 5 |
Nike
NKE
|
+$1.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.29% |
| 2 | Healthcare | 19.73% |
| 3 | Consumer Staples | 17.2% |
| 4 | Industrials | 16.48% |
| 5 | Consumer Discretionary | 8.4% |
Similar funds
SI
KAM
DWT
OQS
RP
HMC
ABTD
FCIM
Saratoga Research & Investment Management's Q2 2014 Portfolio in Review
As of Q2 2014, Saratoga Research & Investment Management held 57 positions worth $1B, up 2.4% from $981M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Saratoga Research & Investment Management's Q2 2014 filing shows 3 new, 22 increased, 17 reduced and 1 closed positions. Its largest new stake was GE Aerospace: 2,066 shares worth $260K. The largest sale was Abbott, an estimated $16.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Staples.
- Saratoga Research & Investment Management's largest Q2 2014 buy was GE Aerospace: 2,066 shares worth $260K.
- Saratoga Research & Investment Management added most to Varian Medical Systems, Inc. in Q2 2014, an estimated $3.68M increase.
- Saratoga Research & Investment Management's biggest Q2 2014 reduction was Novo Nordisk, cutting an estimated $2.58M.
- Saratoga Research & Investment Management fully exited Abbott in Q2 2014, selling an estimated $16.4M.
- Saratoga Research & Investment Management's ten largest holdings make up 47% of its $1B portfolio in Q2 2014.
- Saratoga Research & Investment Management opened 3 new positions and closed 1 in Q2 2014.
- Saratoga Research & Investment Management's portfolio value rose 2.4% quarter-over-quarter to $1B.
Based on Saratoga Research & Investment Management's 13F filing for Q2 2014, filed 6 Aug 2014.